Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Acute lymphocytic leukemia: Biological markers of clinical response
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Acute lymphocytic leukemia: Biological markers of clinical response'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Lymphoblastic Leukemia
100%
Clinical Response
100%
Biological Markers
100%
Leukemic Cells
75%
Disease Control
50%
Working Diagnosis
50%
Current Therapies
50%
Treatment Regimen
25%
Treatment Outcome
25%
Treatment Strategy
25%
Tumor Cells
25%
Cell Population
25%
Human Cancer
25%
Biological Characterization
25%
Specific Risk
25%
Drug Resistance
25%
Effective Means
25%
Proliferative Activity
25%
Clinical Utility
25%
Treatment Failure
25%
Laboratory Methods
25%
Treatment Components
25%
Cell Systems
25%
White Blood Count
25%
Human Will
25%
Cell Growth Regulation
25%
Biological Information
25%
Appropriate Therapy
25%
Minimal Risk
25%
Clinical Methods
25%
Medicine and Dentistry
Biological Marker
100%
Acute Lymphoblastic Leukemia
100%
Disease
75%
High Risk Population
50%
Malignant Neoplasm
25%
Cell Population
25%
Tumor Cell
25%
Drug Resistance
25%
Cell Growth
25%
Karyotype
25%
Growth Regulation
25%
Immunology and Microbiology
High Risk Population
100%
Cell Population
50%
Tumor Cell
50%
Cell Growth
50%
Leukocyte Count
50%
Drug Resistance
50%
Growth Regulation
50%
Laboratory Technique
50%
Karyotype
50%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Acute Lymphoblastic Leukemia
100%
Disease
75%
Malignant Neoplasm
25%
Drug Resistance
25%
Tumor Model
25%